Victory Capital Management
MNTA

Victory Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Victory Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-22,231
Closed -$1.17M – 2624
2020
Q3 		$1.17M Sell
22,231
-2,359
-10% -$97.7K ﹤0.01% 1632
2020
Q2 		$818K Sell
24,590
-13,094
-35% -$417K ﹤0.01% 1817
2020
Q1 		$1.03M Buy
37,684
+22,536
+149% +$627K ﹤0.01% 1839
2019
Q4 		$299K Buy
15,148
+3,606
+31% +$57.7K ﹤0.01% 2203
2019
Q3 		$150K Buy
+11,542
New +$139K ﹤0.01% 2306

Victory Capital Management's MNTA Position: Q4 2020 in Review

Victory Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 22,231 shares — an estimated $1.17M sold.

Victory Capital Management first reported a position in MNTA in Q3 2019 and held it in 5 quarters. The position peaked at $1.17M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Victory Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Victory Capital Management sold 22,231 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.17M.
  • Victory Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2019 and held it in 5 quarters.
  • Victory Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.17M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.